Avitar, Inc.
Diagnostics company announces second closing of private placement
Published in Pharma Investments, Ventures and Law Weekly, April 11th, 2004
In the second closing, which was completed on March 8, 2004, Avitar issued additional convertible preferred stock and warrants. Previously, Avitar raised $1,000,000 gross proceeds in the first closing held on September 30, 2003. On February 27, 2004, Avitar received shareholder approval for both transactions at a special meeting of shareholders. All of the above securities have been placed with one investor.
The securities sold in the second closing of the private placement were 1000 shares of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- AVI BioPharma, Inc.
Neugene maker reports quarterly loss of $0.10 per share - Alfacell Corporation
Savadelis named chief financial officer at pharmaceutical firm - Alnylam Pharmaceuticals, Inc.
Isis Pharmaceuticals enters RNAi alliance - American Oriental Bioengineering
Bioengineering firm expects record revenue growth, income for 2003 - Aspreva Pharmaceuticals Corp.
Autoimmune disease drug maker completes raises $57 million - BioRexis Pharmaceutical Corp.
Biopharmaceutical firm completes $30M series B financing - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
